Citations

Clear

4610 citation(s) found for "Lu, Brian".

Cerebrovascular Vasospasms, Cerebral Sinus Venous Thrombosis, and Rapid Empyema Reaccumulation in a Child with a Coinfection of Fusobacterium nucleatum and Prevotella loescheii
Geiser, Rachel , Zorio, Onilia, Appavu, Brian

Mayo Clinic

Journal of Child Neurology | May 16, 2025 | Volume: 40 | Issue: 7 | Pages: 563-565

10.1177/08830738251339048 | PMID 40375808 Get It

Fusobacterium nucleatum and Prevotella loescheii are anaerobic gram-negative rods that exist in the oral cavity. To our knowledge, pediatric central nervous system complications with these pathogens have not been well described. An 11-year-old previously healthy vaccinated female child presented for 2 weeks of sinusitis that progressed to left arm and leg hemiplegia. Initial neuroimaging demonstrated a superior sagittal sinus thrombosis and a right hemispheric subdural empyema with midline shift, necessitating surgical evacuation. Culture of the subdural accumulation demonstrated coinfection of Fusobacterium nucleatum and Prevotella loescheii . Within 24 hours of evacuation, the patient progressed to have right hemispheric electrographic status epilepticus, with neuroimaging demonstrating reaccumulation of the empyema and a moderate right middle cerebral artery vasospasm. Transcranial doppler ultrasonography of the right middle cerebral artery territory demonstrated mean flow velocities up to 148 cm/s with a Lindengaard ratio of 3.44. The patient underwent repeat subdural evacuation and was managed with intravenous fluids, permissive hypertension, oral nimodipine, and intravenous milrinone. Electrographic status epilepticus was treated with intravenous lacosamide and levetiracetam. Repeat neuroimaging demonstrated improvement in subdural collection size and resolution of vasospasms. She was discharged after 16 days with continued lacosamide and levetiracetam for seizures, and enoxaparin (Lovenox) for the superior sagittal sinus thrombosis. We present a novel pediatric case of Fusobacterium nucleatum and Prevotella loescheii manifesting with rapid subdural empyema reaccumulation after surgical evacuation, status epilepticus, cerebrovascular vasospasms, and cerebral sinus venous thrombosis. Further work is needed to understand the potential neurologic complications of this condition.
Expert Strategies: Skull Base Reconstruction—Global Perspectives, Insights, and Algorithms through a Mixed Methods Approach
Talati, Vidit , Patel, Jagatkumar A. , Nguyen, Theodore V. , Pang, Jonathan C. , Liu, Lauren , Craig, John R. , Papagiannopoulos, Peter , Phillips, Katie M. , Tajudeen, Bobby A. , Adappa, Nithin D. , Sedaghat, Ahmad R. , Anand, Vijay K. , Batra, Pete S., Bergsneider, Marvin, Casiano, Roy R. , Cavallo, Luigi Maria , Cohen, Marc A. , Eloy, Jean Anderson , Evans, James J., Fernandez‐Miranda, Juan C. , Ferrari, Marco , Froelich, Sébastien , Gardner, Paul A. , Gray, Stacey T. , Hanna, Ehab Y., Harvey, Richard J. , Hong, Sang Duk , Hwang, Peter H. , Kong, Doo‐Sik , Lan, Ming‐Ying , Lee, John Y. K. , Levine, Corinna G. , Meço, Cem , Nicolai, Piero, Nyquist, Gurston , Omura, Kazuhiro , Patel, Zara M. , Celda, María Peris, Prevedello, Danny M., Rabinowitz, Mindy, Raza, Shaan M., Sargi, Zoukaa , Schlosser, Rodney J. , Schwartz, Theodore H. , Sindwani, Raj , Stamm, Aldo Cassol , Thorp, Brian D. , Wang, Marilene B. , Wang, Wei‐Hsin , Witterick, Ian , Won, Tae‐Bin , Woodworth, Bradford A. , Wormald, Peter‐John, Zada, Gabriel , Su, Shirley Y. , Kuan, Edward C , Talati, Vidit , Nguyen, Theodore V , Pang, Jonathan C , Craig, John R , Sedaghat, Ahmad R , Wang, Eric W , Ferrari, Marco , Georgalas, Christos , Harvey, Richard J , Hwang, Peter H , Lan, Ming-Ying , Omura, Kazuhiro , Patel, Zara , Neto, Carlos Pinheiro, Schlosser, Rodney J , Snyderman, Carl H , Woodworth, Bradford A , Meço, Cem , Su, Shirley Y , Abiri, Arash , Goshtasbi, Khodayar , Adappa, Nithin D. , Bergsneider, Marvin , Bernal‐Sprekelsen, Manuel , Bleier, Benjamin S. , Cappabianca, Paolo , Carrau, Ricardo L. , Castelnuovo, Paolo , Dallan, Iacopo , El‐Sayed, Ivan H. , Hanna, Ehab Y., Kelly, Daniel F. , Liu, James K. , Locatelli, Davide , McKean, Erin L. , Nicolai, Piero , Passeri, Thibault , Pinheiro‐Neto, Carlos , Prevedello, Danny M., Recinos, Pablo F. , Rosen, Marc R , Turri‐Zanoni, Mario , Wormald, Peter‐John

Mayo Clinic

International Forum of Allergy & Rhinology | May 15, 2025 | Volume: 15 | Issue: 10 | Pages: 1032-1069

10.1002/alr.23596 | PMID 40371737 Get It

ABSTRACT Objective There is limited consensus on endoscopic skull base surgery (ESBS) reconstruction principles. This study aims to generate comprehensive themes regarding ESBS reconstruction by pooling the experiences of ESBS experts, with comparison to a literature review of current published evidence. Methods Structured qualitative interviews of ESBS experts regarding postoperative management and reconstruction of various defect locations were conducted. Results A total of 68 experts comprising 40 academic teams across 13 countries with an average of 18 years of ESBS experience were included. We propose 10 stepwise algorithms for common skull base reconstruction scenarios based on these expert interviews. When available, the nasoseptal flap is used for all high_flow cerebrospinal leak defects. Multilayered reconstruction is favored at all anatomical subsites with increasing number of layers for increasing defect size and complexity. Heterogeneity exists in terms of inlay technique and materials, free grafting versus various pedicled flap options for low‐flow defects or in the absence of a nasal septum, nasal packing, tissue sealant, lumbar drain use, and postoperative management. Commonalities and discrepancies between experts were summarized. Conclusion Skull base reconstruction and post‐ESBS management is highly complex with a wide variety of practice patterns and expert strategies. Further research of higher quality evidence is warranted to identify optimal management patterns, though the current work aims to inform surgeons on these controversial areas by drawing from numerous experiences.
Rizatriptan vs Placebo for Attacks of Vestibular Migraine
Eggers, Scott D.Z. , Jen, Joanna C. , Geske, Jennifer R. , Hofschulte, Deanna R., Gonzalez, Gabrielle F , Neff, Brian A., Shepard, Neil T., McCaslin, Devin L. , Baloh, Robert W., Geske, Jennifer , Staab, Jeffrey P. , LeMahieu, Allison , Liu, Honghu

Mayo Clinic

JAMA Neurology | May 12, 2025 | Volume: 82 | Issue: 7 | Pages: 676

10.1001/jamaneurol.2025.1006 | PMID 40354049 Get It

ImportanceVestibular migraine has no established treatments.ObjectiveTo test the efficacy of rizatriptan for treating vestibular migraine attacks.Design, Setting, and ParticipantsThis double-blind, randomized clinical trial of rizatriptan vs placebo was conducted from December 2014 through July 2020 (data analyses in 2021 and sensitivity analyses in 2022 and 2024) at 2 tertiary neurotologic centers. Adults with vestibular migraine were included.InterventionAll participants underwent prospective observation to confirm diagnosis and illness activity and were then randomized in a 2:1 ratio to receive rizatriptan 10 mg or placebo to treat up to 3 vestibular migraine attacks per participant.Main Outcomes and MeasuresParticipants rated symptoms as absent, mild, moderate, or severe at scheduled intervals. Primary outcomes were the percentage of attacks with reductions in vertigo and unsteadiness/dizziness from moderate or severe to absent or mild at 1 hour. Secondary outcomes were the percentage of attacks with complete resolution of vestibular symptoms at 1 hour; reductions in headache and associated symptoms at 1 hour; use of rescue medications after 1 hour; reductions in vestibular, headache, and associated symptoms at 24 hours without rescue medications; treatment satisfaction and quality of life at 48 hours; and rates of serious adverse effects and discontinuation due to adverse effects.ResultsOf 222 total participants (mean [SD] age, 42.3 [11.7] years; 70.7% were women), 134 (60.4%) with active illness treated 307 attacks. Efficacy was tested using 240 attacks with vestibular symptoms rated as moderate or severe when participants took study drug. At 1 hour, rizatriptan did not differ from placebo for reducing vertigo (73/151 [48.3%] vs 50/88 [56.8%] attacks; odds ratio [OR], 0.71 [95% CI, 0.42-1.21]), unsteadiness/dizziness (29/151 [19.2%] vs 11/89 [12.4%] attacks; OR, 1.69 [95% CI, 0.80-3.57]), or any secondary outcomes. Similar percentages of participants in rizatriptan and placebo groups (26.4% for both groups) added rescue remedies after 1 hour. At 24 hours, rizatriptan had medium effects over placebo for unsteadiness/dizziness (OR, 2.65) and motion sensitivity (OR, 3.58). Post hoc analyses of all treated attacks found a medium effect favoring rizatriptan for headache and photophobia or phonophobia at 24 hours. Treatment satisfaction was equivocal. Quality of life was mixed. No participants experienced serious adverse effects or discontinued treatment for adverse effects.Conclusions and RelevanceIn this study, rizatriptan was ineffective at 1 hour for treating vestibular migraine attacks and had limited benefit on symptoms at 24 hours. Findings do not support using rizatriptan for vestibular migraine attacks.Trial RegistrationClinicalTrials.gov Identifier: NCT02447991
Urodynamics for Female Stress Urinary Incontinence: When and Why
Pfeuti, Courtney K. , Przydacz, Mikołaj , Linder, Brian J. , Linder, Brian J

Mayo Clinic

Neurourology and Urodynamics | May 12, 2025 | Volume: 45 | Issue: 2 | Pages: 254-261

10.1002/nau.70073 | PMID 40351243 Get It

ABSTRACT Aims To discuss the use of urodynamic testing for female stress urinary incontinence and provide a narrative review of the current evidence regarding the utility of urodynamics across the spectrum of clinical presentations. Methods A nonsystemic, extensive literature review via PubMed was performed on the use of urodynamics for female stress urinary incontinence. Results Findings from several large multicenter trials and subsequent secondary analyses have significantly influenced treatment patterns away from the routine use of urodynamics in female patients with uncomplicated stress urinary incontinence. Much of the current literature focuses on selected patients with uncomplicated stress urinary incontinence that are subsequently treated with midurethral sling placement. These studies comprise the foundational evidence supporting multiple national and international guidelines on the topic. In uncomplicated patients, these guidelines do not support the routine use of urodynamics. However, in more complicated presentations, urodynamic studies are more often valuable for diagnosis and management. Conclusions Routine use of urodynamic testing is not currently recommended in guidelines for evaluating uncomplicated female stress urinary incontinence. It is important to recognize that much of the evidence supporting these recommendations is derived from a select population of uncomplicated patients, which may limit generalizability to more complex cases. In such cases, urodynamic testing may be more useful to guide diagnosis and management, though further research is needed to identify which findings have the greatest impact on clinical outcomes.
CEDAR General/Implementation
Strechen, Inna , Pickering, Brian W. , Smith-Stellflug, Jamie L, Hamann, Brianne R., Heise, Katherine J., Tiong, Ing , Argue, David P., Barwise, Amelia , Herasevich, Svetlana , Herasevich, Vitaly , Ridgeway, Jennifer L. , Chang, Yu‐Hui

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A5597-A5597

10.1164/ajrccm.2025.211.abstracts.a5597 Get It

Abstract Rationale: Ongoing healthcare staffing shortages have prompted new care paradigms that incorporate remote care delivery to support timely detection of patient physiological deterioration through mechanisms other than clinician bedside evaluations. In partnership with institutional Information Technology, our team has developed a unique clinical informatics environment, known as the Advanced Medical Practice (AMP) platform, that incorporates data from multiple sources and platforms and supports remote observation of patients from the electronic intensive care unit(eICU). AMP takes advantage of technologies outside of vendor-supported EHRs, and its advanced user-interface design reduces information overload while incorporating real-time data from novel devices and sensors. We partnered with the hospital practice to co-develop a score within the AMP platform(Clinical Events Detection and Response[CEDAR]) that incorporates heart rate, blood pressure, respiratory rate, and SpO2 to stratify patient risk and generate deterioration alerts for the electronic ICU(eICU) team. This formative evaluation employed an implementation science approach to refine CEDAR and ensure it is acceptable to users and can be feasibly implemented in practice. Methods: The study team conducted this pilot work in the eICU at Mayo Clinic (Rochester, MN). We observed the eICU workflow and documented feedback from eICU staff in fieldnotes. eICU staff were asked to log issues in a tracking file during shifts. Issues were reviewed daily and discussed at multidisciplinary team meetings weekly. Observation and tracking data were coded to constructs in the Consolidated Framework for Implementation Research(CFIR 2.0) framework and mapped to Expert Recommendations for Implementation Change(ERIC) strategies that targeted key determinants. Results: Between 9/23/24 and 10/25/24 we completed 25 days of observations. Most identified issues related to technical/design issues like unclear vital trigger alerts (CFIR: Innovation trialability and design); staff knowledge of CEDAR functionality and attitudes about functionality, complexity, or relative advantage compared to current systems (CFIR: Inner setting access to knowledge and information and relative advantage); and difficulties incorporating CEDAR into workflow(CFIR: Inner setting/compatibility). Implementation strategies mapped to CFIR determinants included promoting adaptability of customized interface features; staging implementation scale-up with iterative improvements; providing local technical assistance; assessing for readiness and identifying facilitators and barriers; and conducting educational outreach visits. Conclusions: Formative evaluation during pilot studies are a critical step in the process of intervention development and testing. User engagement and frameworks from implementation science can identify issues of feasibility and inform strategies to ensure acceptability prior to intervention scale-up in clinical practice and readiness for conducting larger implementation studies.
Using Computer-aided Lung Informatics for Pathology Evaluation and Ratings (CALIPER) to Differentiate Immune Checkpoint Inhibitor (ICI) and Radiation Pneumonitis From Infectious Pneumonitis
Karanam, V., LeMaheiu, A., Bartholmai, Brian J. , Egan, Michael

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A1716-A1716

10.1164/ajrccm.2025.211.abstracts.a1716 Get It

Abstract Rationale Immune checkpoint inhibitors (ICI) have become standard care for many cancers. Their mechanism of action mediates immune related adverse events including ICI pneumonitis. Diagnosis of this is difficult to differentiate from infectious and radiation pneumonitis as it is a diagnosis of exclusion often requiring bronchoscopy and imaging interpreted by expert radiologists. This study investigates the use of CALIPER, a computer-aided lung informatics program, in identifying differences between Computed Tomography (CT) patterns in ICI, radiation, and infectious pneumonitis that may aid in diagnosis noninvasively. Methods CT images of ten patients with ICI pneumonitis, ten patients with infectious pneumonitis, and nine patients with radiation pneumonitis, all diagnosed by clinical expertise and evaluation with bronchoalveolar lavage, were analyzed with CALIPER. CALIPER classified each CT voxel into either vessel-related structures (VRS), normal, mild low-attenuation area (LAA), moderate LAA, severe LAA, reticular (R), honeycomb (HC) or ground-glass (GG) features. Each lung was divided into upper, middle, and lower lobes. Exploratory analyses explored the relationship between CALIPER components and diagnosis, comparing ICI and radiation pneumonitis with infectious pneumonitis. Diagnosis was analyzed using multinomial logistic regression adjusted for presence of pleural effusion. Additionally, diagnosis was assessed as infectious versus a pooled group of radiation and ICI pneumonitis and analyzed using logistic regression adjusted for pleural effusion. Due to the exploratory nature of analysis, no correction was applied for multiplicity of testing. Results Twenty-nine patients were analyzed. ICI pneumonitis patients had less moderate low attenuation in the left upper (p = 0.016) and middle peripheral lung (p = 0.038), and radiation pneumonitis patients had less moderate low attenuation in the left upper peripheral lung (p = 0.031). When comparing the pooled group of ICI and radiation pneumonitis images with infectious pneumonitis, there was more moderate LAA in left upper (0.012) and middle (0.034) peripheral lung in the pooled group compared to infectious pneumonitis. There was no association with VRS, GG, HC, R, mild, or severe LAA patterns. Conclusions Although areas of moderate low attenuation were more prevalent for infectious pneumonitis, these results taken in the context of low sample size, exploratory analysis, and lack of clinical reasoning to support these findings make them likely insignificant. Based on this limited exploratory analysis, it is unlikely that we can solely use CALIPER as noninvasive evaluation to differentiate radiation and ICI pneumonitis from infectious pneumonitis. This highlights the need for a more robust program to aid in noninvasive diagnosis.
Tracheostomy Care: A Hospital's Dilemma
Noland, D., Fouty, Brian, Petrossian, R., Yendrapalli, U. , Grannum, M.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A1533-A1533

10.1164/ajrccm.2025.211.abstracts.a1533 Get It

Abstract Rationale: Tracheostomies are commonly placed to facilitate weaning from ventilators in ICU patients who fail extubation. Once these patients are successfully weaned from mechanical ventilation and transferred out of the ICU however, management of the tracheostomies are frequently left to the floor teams that are less experienced in managing them. This can delay downsizing/removing tracheostomies when appropriate or in exchanging them when they cannot be safely removed. This report details the number and type of patients with tracheostomies and describes their tracheostomy management after placement.in a small university hospital that did not have a dedicated tracheostomy team. Methods: We reviewed the charts of all patients with tracheostomies who were in the hospital on a single day (7/22/2024). Patients were categorized based on which service placed the initial trach, the reason for the tracheostomy placement, the time from the initial trach placement, and the most recent exchange date. Results: Twelve patients with tracheostomies were in the hospital on that day (4% of all hospitalized patients); six were still in the ICU and 6 were on the floor. The time from initial tracheostomy placement ranged from 10 days to 2.5 years. The primary indications for tracheostomy included respiratory failure (n=5), cerebrovascular accidents (CVA) (n=4), and trauma (n=3). Eight tracheostomies were placed by the Surgery/Trauma service, three by the ENT service, and one by an outside hospital. At the time of data collection 5 of the 12 patients had not yet received a first trach exchange with an average time from tracheostomy placement of >20 days. Three of the 12 patients had had their trach downsized at least once. At least 4 patients had not had a documented tracheostomy exchange for at least 2 months. Conclusion: Our findings emphasize the diverse clinical situations requiring tracheostomy and their impact on patient care in and out of the ICU. The study highlights the importance of continuous assessment throughout a patient's hospital stay. In at least four cases, tracheostomy exchange intervals exceeded the recommended monthly timeframe. Research indicates that tracheostomy teams improve patient safety and outcomes through standardized protocols, suggesting a need for further investigation into team dynamics and their role in recovery.
A Proposal for HPV-Associated Oropharyngeal Carcinoma in the Ninth Edition Clinical TNM Classification
Huang, Shao Hui, Su, Jie , Koyfman, Shlomo A. , Hoebers, Frank , Bahig, Houda , Yu, Eugene , Bartlett, Eric , Davis, Robin L. , Woody, N.M. , Nelson, Kristoff , Lavigne, Danny , Nguyen‐Tan, Phuc Félix, Létourneau‐Guillon, Laurent , Filion, Édith, Nagelschneider, Alex A. , Abel, Kathryn M. Van , Postma, Alida A. , Palm, Walter M. , Lydiatt, William M. , Patel, Snehal G. , Routman, David, Van Abel, Kathryn M , Huang, Shao Hui, Routman, David M. , Spreafico, Anna , Lee, Jonathan Wei Jie , Stock, Sarah Jane , Daniel, J. , Hoeben, Ann , Chua, Melvin L.K. , Xu, Wei , O'Sullivan, Brian P

Mayo Clinic

JAMA Otolaryngology–Head & Neck Surgery | May 8, 2025 | Volume: 151 | Issue: 7 | Pages: 655

10.1001/jamaoto.2025.0848 | PMID 40338536 Get It

Importance A subset of Union for International Cancer Control ( UICC )/ American Joint Committee on Cancer ( AJCC ) eighth edition TNM stage I and II human papillomavirus–positive oropharyngeal carcinoma has undesirable outcomes, which might have contributed to a lack of success in phase III deintensification trials. Refining clinical stage groups, especially in the overabundant cN1/stage I group, has become important for treatment selection. Objective To assess the prognostic importance of pretreatment lymph node (LN) characteristics to optimize case distribution and outcome homogeneity within the N classification system. Design, Setting, and Participants This is an international multi-institutional retrospective prognostic cohort study. Analysis of human papillomavirus–positive oropharyngeal carcinoma treated curatively from 4 institutions (International Collaboration of Oropharyngeal Cancer Network for N-Classification [ICON-N] dataset) provided a refined clinical staging proposal; an independent dataset (Centre Hospitalier de l’Université de Montréal [CHUM] dataset) validated the proposal. Neuroradiologists reviewed pretreatment computed tomography and/or magnetic resonance imaging for nodal features, including presence or absence of abnormal LN(s), retropharyngeal LN, laterality, number of abnormal LN, and imaging-detected extranodal extension (iENE). Data were collected from February to May 2023, and data were analyzed from June to July 2023. Exposures Definitive chemoradiotherapy/radiotherapy or definitive surgery with or without postoperative chemoradiotherapy/radiotherapy. Main Outcomes and Measures The primary end point was overall survival. A Cox proportional hazards multivariable model was used to estimate adjusted hazard ratios (AHRs) and to derive an optimal clinical TNM stage classification (AHR-stage schema) incorporating the strongest prognostic nodal features within the UICC/AJCC eighth edition TNM framework after confirming the prognostication of iENE status. The performance (according to overall normalized scores and ranking) of the AHR-stage schema against the current UICC/AJCC eighth edition TNM staging system was evaluated for hazard consistency, hazard discrimination, prognostic importance, and sample size balance. Validation was performed in the CHUM dataset. Results The ICON-N dataset comprised 2053 patients, including 1898 (92.5%) with cN-positive disease and 155 (7.5%) with cN0 disease; a total of 298 (14.5%) were female, and the mean (SD) age was 60.6 (9.3) years. iENE-positive disease was identified in 710 of 1898 patients with cN-positive disease (37.4%). The median (range) follow-up was 5.1 (0.1-14.7) years. iENE was the strongest prognostic nodal feature in multivariable analysis; the AHR for iENE-positive vs iENE-positive disease was 2.43 (95% CI, 1.96-3.03) in the ICON-N dataset and 2.04 (95% CI, 1.28-3.23) in the CHUM dataset (n = 451). Reclassifying iENE-positive cases 1 stratum higher for N categorization without altering iENE-negative cases yielded an AHR-stage schema that outperformed the current TNM staging system in disease-free and overall survival with a lower (ie, better) overall normalized score (2 vs 3). Conclusions and Relevance In this study, reclassifying each N category 1 stratum higher for iENE-positive disease resulted in better disease-free and overall survival. The proposed new classification outperformed the currently TNM staging system in risk stratification and may facilitate future clinical trial design, outcomes research, and patient care.
Percutaneous Ablation of Parathyroid Adenomas: A Systematic Review and Meta-Analysis
Bilgin, Cem , Oztepe, Firat, Sfeir, Jad , Wermers, Robert A. , Schmitz, John J. , Welch, Brian T. , Lee, Robert A. , Parvinian, Ahmad , Hibbert, Rebecca , Sfeir, Jad G , Adamo, Daniel A. , Parvinian, Ahmad , Bilgin, Cem

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | May 6, 2025 | Volume: 110 | Issue: 9 | Pages: e3150-e3162

10.1210/clinem/dgaf270 | PMID 40326768 Get It

Abstract Background Percutaneous ablation of parathyroid adenomas provides a minimally invasive treatment option for primary hyperparathyroidism. However, the overall performance of this technique remains underexplored. This meta-analysis evaluates the effectiveness and safety of various ablation techniques for parathyroid adenomas. Methods Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, multiple databases, including Ovid MEDLINE and Cochrane, were systematically searched. Studies that provided separate data for radiofrequency (RF), microwave ablation (MWA), and ethanol ablation technique were included. Outcomes of interest were changes in serum calcium, PTH, and phosphorus levels, along with normocalcemia rates at 6 to 12 months after ablation. Safety outcomes included transient hoarseness, permanent hoarseness, severe hemorrhage, major complications, and severe hypocalcemia. Data were pooled using a random-effects model, with pooled prevalence and 95% CIs calculated. Also, the publication bias was assessed with Egger's test for each outcome measure. Results Twenty studies (815 patients) were included. The posttreatment normocalcemia rate at 6 to 12 months was 85.6% (95% CI, 80.48-90.72). Serum PTH and calcium levels significantly decreased, with mean differences of 101.49 pg/mL (95% CI, 73.50-129.48) and 0.39 mmol/L (95% CI, 0.34-.45), respectively. Permanent hoarseness and major complications were rare, with incidences of 0.28% (95% CI, 0.00-1.05) and 0.31% (95% CI, 0.00-1.09). The safety and efficacy outcomes of RF, MWA, and ethanol ablation were comparable. Conclusion Our findings indicate that percutaneous ablation of parathyroid adenomas is safe and effective within the first year of the treatment. Additionally, they suggest that RF, MWA, and ethanol ablation techniques can each be employed depending on patients' needs without particular limitations.